Skip to content

Comparison of sclerotherapy and laparoscopic cystectomy on ovarian reserve and disease relapse in patients with ovarian endometriosis

Evaluation and comparison of the sclerotherapy and laparoscopic cystectomy on the ovarian reserve and the disease relapse of patients with ovarian endometriosis in university hospitals, Isfahan

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171030037093N31
Enrollment
70
Registered
2020-03-05
Start date
2020-02-20
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian endometriosis. Endometriosis of ovary

Interventions

Intervention 1: First intervention group: The first group will consist of 35 patients undergoing sclerotherapy with cook needle under sedation. The method of treatment for sclerotherapy is that trans

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Detection of endometriosis by ultrasound or MRI Patient Satisfaction for Inclusion Ages over 18 years No doubt to malignancy Abnormal amounts of CA125 tumor marker Having infertility Having chronic pelvic pain Ovarian cysts about 4-8 cm

Exclusion criteria

Exclusion criteria: Patients whose information is incomplete Non-endometriotic ovarian masses History of any malignancy

Design outcomes

Primary

MeasureTime frame
Recurrence of endometriosis lesions. Timepoint: 12 weeks after interventon. Method of measurement: Sonography.;Ovarian reserve. Timepoint: 12 weeks after interventon. Method of measurement: Measurement of anti-mullerian hormoneserum levels.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHatav Ghasemi Tehrani

Esfahan University of Medical Sciences

Hatav.tehrani2014@gmail.com+98 31 3445 2031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026